Literature DB >> 18936555

Dysphagia in inclusion body myositis: clinical features, management, and clinical outcome.

Terry H Oh1, Kathlyn A Brumfield, Tanya L Hoskin, Jan L Kasperbauer, Jeffrey R Basford.   

Abstract

OBJECTIVE: To evaluate the clinical features, treatment strategies, and outcome of dysphagia in patients with inclusion body myositis.
DESIGN: Retrospective review of all 26 patients (20 women, 6 men, mean age of 72.2 yrs) with inclusion body myositis-associated dysphagia seen in 1997-2001 at our institution.
RESULTS: Twenty-four patients (92%) had a dysphagia evaluation. Cricopharyngeal muscle dysfunction was noted in all nine patients who had barium swallow studies. Eighteen patients (69%) underwent one or more interventional procedures: cricopharyngeal myotomy (10), pharyngoesophageal dilation (6), percutaneous endoscopic gastrostomy (6), and botulinum injection of the upper esophageal sphincter (2). Dysphagia tended to worsen with time. Symptomatic improvement was noted with cricopharyngeal myotomy (63%) and pharyngoesophageal dilation (33%). The Mendelsohn maneuver seemed helpful in maintaining oral intake in the three patients in whom it was recommended. Thirteen patients died during follow-up at a mean age of 81 yrs. The cause of death was identified in eight and in all cases was because of the respiratory complications of aspiration.
CONCLUSIONS: Dysphagia is a progressive condition in patients with inclusion body myositis and often leads to death from aspiration pneumonia. Treatment targeting cricopharyngeal muscle dysfunction, such as the Mendelsohn maneuver, will benefit from further investigation.

Entities:  

Mesh:

Year:  2008        PMID: 18936555     DOI: 10.1097/PHM.0b013e31818a50e2

Source DB:  PubMed          Journal:  Am J Phys Med Rehabil        ISSN: 0894-9115            Impact factor:   2.159


  24 in total

1.  Effects of Mendelsohn maneuver on measures of swallowing duration post stroke.

Authors:  Gary H McCullough; Erin Kamarunas; Giselle C Mann; James W Schmidley; Joanne A Robbins; Michael A Crary
Journal:  Top Stroke Rehabil       Date:  2012 May-Jun       Impact factor: 2.119

2.  The Relationship Between Hiatal Hernia and Cricopharyngeus Muscle Dysfunction.

Authors:  Nogah Nativ-Zeltzer; Anaïs Rameau; Maggie A Kuhn; Matthew Kaufman; Peter C Belafsky
Journal:  Dysphagia       Date:  2018-11-07       Impact factor: 3.438

Review 3.  Update on treatment of inclusion body myositis.

Authors:  Maren Breithaupt; Jens Schmidt
Journal:  Curr Rheumatol Rep       Date:  2013-05       Impact factor: 4.592

4.  Speech pathologist practice patterns for evaluation and management of suspected cricopharyngeal dysfunction.

Authors:  Corinne A Jones; Molly A Knigge; Timothy M McCulloch
Journal:  Dysphagia       Date:  2014-02-06       Impact factor: 3.438

Review 5.  Inclusion Body Myositis: Update on Pathogenesis and Treatment.

Authors:  Elie Naddaf; Richard J Barohn; Mazen M Dimachkie
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

6.  Dysphagia in inflammatory myopathy: self-report, incidence, and prevalence.

Authors:  Kylie Patricia Mulcahy; Patricia Claire Langdon; Francis Mastaglia
Journal:  Dysphagia       Date:  2011-03-27       Impact factor: 3.438

7.  Cricopharyngeal myotomy for cricopharyngeus stricture in an inclusion body myositis patient with hiatus hernia: a learning experience.

Authors:  Ali Sanei-Moghaddam; Sanjiv Kumar; Piyush Jani; Charlotte Brierley
Journal:  BMJ Case Rep       Date:  2013-01-22

8.  Cricopharyngeal bar on videofluoroscopy: high specificity for inclusion body myositis.

Authors:  Kenichiro Taira; Toshiyuki Yamamoto; Madoka Mori-Yoshimura; Kazuaki Sajima; Hotake Takizawa; Jun Shinmi; Yasushi Oya; Ichizo Nishino; Yuji Takahashi
Journal:  J Neurol       Date:  2020-09-26       Impact factor: 4.849

Review 9.  Diagnosis, pathogenesis and treatment of myositis: recent advances.

Authors:  P-O Carstens; J Schmidt
Journal:  Clin Exp Immunol       Date:  2014-03       Impact factor: 4.330

10.  Detecting dysphagia in inclusion body myositis.

Authors:  F M Cox; J J Verschuuren; B M Verbist; E H Niks; A R Wintzen; U A Badrising
Journal:  J Neurol       Date:  2009-07-15       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.